Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
USD 18.51
(5.05%)
USD 18.51
(5.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 462.5 Million | - | - | - |
| Cost of Revenue | 3.36 Million | 1.38 Million | 91.66 Million | 72 Thousand | - | - |
| Gross Profit | -3.36 Million | -1.38 Million | 370.84 Million | -72 Thousand | - | - |
| Operating Expenses | 436.05 Million | 567.93 Million | 218.9 Million | 114.5 Million | 479.12 Million | - |
| Selling, General and Administrative Expenses | 62.77 Million | 130.86 Million | 37.41 Million | 16.04 Million | 134.44 Million | - |
| Research and Development Expenses | 373.28 Million | 437.07 Million | 181.48 Million | 98.46 Million | 344.67 Million | - |
| Other Expenses | - | -1.9 Million | 1.2 Million | - | - | - |
| Cost and Expenses | 436.05 Million | 567.93 Million | 218.9 Million | 114.5 Million | 479.12 Million | - |
| Operating Income | -436.05 Million | -567.93 Million | -218.9 Million | -114.5 Million | -479.12 Million | - |
| Interest Expense | - | - | - | - | -12.71 Million | - |
| Income Tax Expense | -1.38 Million | 438 Thousand | 1.36 Million | -134.29 Thousand | 419 Thousand | - |
| Earnings before Tax | -409.55 Million | -569.84 Million | -212.43 Million | -118.66 Million | -528.38 Million | - |
| Net Income | -408.16 Million | -570.27 Million | -213.79 Million | -118.66 Million | -528.8 Million | - |
| Earnings Per Share Basic | -5.73 | -12.75 | -5.97 | -3.31 | -10.91 | - |
| Earnings Per Share Diluted | -5.73 | -12.75 | -5.97 | -3.31 | -10.91 | - |
| Weighted Average Shares Outstanding | 71.2 Million | 44.74 Million | 35.82 Million | 35.82 Million | 48.48 Million | - |
| Weighted Average Shares Outstanding (Diluted) | 71.2 Million | 44.74 Million | 35.82 Million | 35.82 Million | 48.48 Million | - |
| Gross Margin | - | - | 0.80 | - | - | - |
| EBIT Margin | - | - | -0.47 | - | - | - |
| Profit Margin | - | - | -0.46 | - | - | - |
| EBITDA | -429.13 Million | -462.79 Million | -217.5 Million | -114.43 Million | -479.12 Million | - |
| Earnings Before Tax Margin | - | - | -0.47 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 977 Thousand | 941 Thousand | 948 Thousand | 3.36 Million | 857 Thousand | 800 Thousand |
| Gross Profit | -977 Thousand | -941 Thousand | -948 Thousand | -3.36 Million | -857 Thousand | -800 Thousand |
| Operating Expenses | 332.79 Million | 182.29 Million | 152.76 Million | 432.68 Million | 110.54 Million | 94.01 Million |
| Selling, General and Administrative Expenses | 17.97 Million | 26.32 Million | 17.95 Million | - | 15.03 Million | 14.52 Million |
| Research and Development Expenses | 314.81 Million | 155.97 Million | 134.81 Million | - | 95.51 Million | 79.49 Million |
| Other Expenses | 14.17 Million | 4.3 Million | 7.74 Million | - | 4.68 Million | 5.84 Million |
| Cost and Expenses | 333.77 Million | 183.24 Million | 153.71 Million | 436.05 Million | 110.54 Million | 94.01 Million |
| Operating Income | -333.77 Million | -183.24 Million | -153.71 Million | -436.05 Million | -110.54 Million | -94.01 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 177 Thousand | 569 Thousand | -1.21 Million | -1.38 Million | -3.28 Million | 2.17 Million |
| Earnings before Tax | -319.59 Million | -178.93 Million | -145.96 Million | -409.55 Million | -105.86 Million | -88.16 Million |
| Net Income | -319.77 Million | -179.5 Million | -144.75 Million | -408.16 Million | -102.57 Million | -90.34 Million |
| Earnings Per Share Basic | -3.64 | -2.20 | -1.81 | - | -1.50 | -1.32 |
| Earnings Per Share Diluted | -3.64 | -2.20 | -1.81 | - | -1.50 | -1.32 |
| Weighted Average Shares Outstanding | 87.76 Million | 81.6 Million | 79.92 Million | 71.2 Million | 68.32 Million | 68.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 87.76 Million | 81.6 Million | 79.92 Million | 71.2 Million | 68.32 Million | 68.24 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -332.79 Million | -182.29 Million | -152.76 Million | - | -110.54 Million | -92.18 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
3109
0MJH
3908
RIGL
5401
FATBW